{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:13:35Z","timestamp":1791159215837,"version":"4.1.0"},"reference-count":190,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,4,14]],"date-time":"2015-04-14T00:00:00Z","timestamp":1428969600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1038\/nrneph.2015.39","type":"journal-article","created":{"date-parts":[[2015,4,14]],"date-time":"2015-04-14T02:34:17Z","timestamp":1428978857000},"page":"451-464","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":126,"title":["Vasopressin and disruption of calcium signalling in polycystic kidney disease"],"prefix":"10.1038","volume":"11","author":[{"given":"Fouad T.","family":"Chebib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline R.","family":"Sussman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente E.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,14]]},"reference":[{"key":"BFnrneph201539_CR1","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","volume":"369","author":"VE Torres","year":"2007","unstructured":"Torres, V. E., Harris, P. C. & Pirson, Y. Autosomal dominant polycystic kidney disease. Lancet 369, 1287\u20131301 (2007).","journal-title":"Lancet"},{"key":"BFnrneph201539_CR2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev.med.60.101707.125712","volume":"60","author":"PC Harris","year":"2009","unstructured":"Harris, P. C. & Torres, V. E. Polycystic kidney disease. Annu. Rev. Med. 60, 321\u2013327 (2009).","journal-title":"Annu. Rev. Med."},{"key":"BFnrneph201539_CR3","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.2215\/CJN.00780110","volume":"5","author":"KL Lentine","year":"2010","unstructured":"Lentine, K. L., Xiao, H., Machnicki, G., Gheorghian, A. & Schnitzler. M. A. Renal function and healthcare costs in patients with polycystic kidney disease. Clin. J. Am. Soc. Nephrol. 5, 1471\u20131479 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"Suppl. 4","key":"BFnrneph201539_CR4","doi-asserted-by":"publisher","first-page":"iv15","DOI":"10.1093\/ndt\/gfu017","volume":"29","author":"EM Spithoven","year":"2014","unstructured":"Spithoven, E. M. et al. Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival\u2014an analysis of data from the ERA-EDTA Registry. Nephrol. Dial. Transplant. 29 (Suppl. 4), iv15\u2013iv25 (2014).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201539_CR5","doi-asserted-by":"crossref","unstructured":"The European Polycystic Kidney Disease Consortium. The polycystic kidney disease 1 gene encodes a 14kb transcript and lies within a duplicated region on chromosome 16. Cell 77, 881\u2013894 (1994).","DOI":"10.1016\/0092-8674(94)90137-6"},{"key":"BFnrneph201539_CR6","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1126\/science.272.5266.1339","volume":"272","author":"T Mochizuki","year":"1996","unstructured":"Mochizuki, T. et al. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272, 1339\u20131342 (1996).","journal-title":"Science"},{"key":"BFnrneph201539_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/ng0695-151","volume":"10","author":"J Hughes","year":"1995","unstructured":"Hughes, J. et al. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat. Genet. 10, 151\u2013160 (1995).","journal-title":"Nat. Genet."},{"key":"BFnrneph201539_CR8","doi-asserted-by":"crossref","unstructured":"The International Polycystic Kidney Disease Consortium. Polycystic kidney disease: the complete structure of the PKD1 gene and its protein. Cell 81, 289\u2013298 (1995).","DOI":"10.1016\/0092-8674(95)90339-9"},{"key":"BFnrneph201539_CR9","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1056\/NEJMoa054341","volume":"354","author":"JJ Grantham","year":"2006","unstructured":"Grantham, J. J. et al. Volume progression in polycystic kidney disease. N. Engl. J. Med. 354, 2122\u20132130 (2006).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201539_CR10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.2215\/CJN.09500911","volume":"7","author":"AB Chapman","year":"2012","unstructured":"Chapman, A. B. et al. Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease. Clin. J. Am. Soc. Nephrol. 7, 479\u2013486 (2012).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201539_CR11","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","volume":"367","author":"VE Torres","year":"2012","unstructured":"Torres, V. E. et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N. Engl. J. Med. 367, 2407\u20132418 (2012).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201539_CR12","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/S0140-6736(13)61407-5","volume":"382","author":"A Caroli","year":"2013","unstructured":"Caroli, A. et al. Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial. Lancet 382, 1485\u20131495 (2013).","journal-title":"Lancet"},{"key":"BFnrneph201539_CR13","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMoa1402685","volume":"37","author":"RS Schrier","year":"2014","unstructured":"Schrier, R. S. et al. Blood pressure in early autosomal dominant polycystic kidney disease. N. Engl. J. Med. 37, 2255\u20132266 (2014).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201539_CR14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/ng0697-179","volume":"16","author":"F Qian","year":"1997","unstructured":"Qian, F. et al. PKD1 interacts with PKD2 through a probable coiled-coil domain. Nat. Genet. 16, 179\u2013183 (1997).","journal-title":"Nat. Genet."},{"key":"BFnrneph201539_CR15","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/emboj.2012.26","volume":"31","author":"D Ara\u00e7","year":"2012","unstructured":"Ara\u00e7, D. et al. A novel evolutionarily conserved domain of cell-adhesion GPCRs mediates autoproteolysis. EMBO J. 31, 1364\u20131378 (2012).","journal-title":"EMBO J."},{"key":"BFnrneph201539_CR16","doi-asserted-by":"publisher","first-page":"18688","DOI":"10.1073\/pnas.0708217104","volume":"104","author":"S Yu","year":"2007","unstructured":"Yu, S. et al. Essential role of cleavage of polycystin-1 at G protein-coupled receptor proteolytic site for kidney tubular structure. Proc. Natl Acad. Sci. USA 104, 18688\u201318693 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201539_CR17","doi-asserted-by":"publisher","first-page":"16981","DOI":"10.1073\/pnas.252484899","volume":"99","author":"F Qian","year":"2002","unstructured":"Qian, F. et al. Cleavage of polycystin-1 requires the receptor for egg jelly domain and is disrupted by human autosomal-dominant polycystic kidney disease 1-associated mutations. Proc. Natl Acad. Sci. USA 99, 16981\u201316986 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201539_CR18","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1681\/ASN.2008060564","volume":"20","author":"M Hogan","year":"2009","unstructured":"Hogan, M. et al. Characterization of PKD protein-positive exosome-like vesicles. J. Am. Soc. Nephrol. 20, 278\u2013288 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201539_CR19","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1172\/JCI64313","volume":"122","author":"K Hopp","year":"2012","unstructured":"Hopp, K. et al. Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity. J. Clin. Invest. 122, 4257\u20134273 (2012).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201539_CR20","doi-asserted-by":"publisher","first-page":"e12305","DOI":"10.1371\/journal.pone.0012305","volume":"5","author":"OM Woodward","year":"2010","unstructured":"Woodward, O. M. et al. Identification of a polycystin-1 cleavage product, P100, that regulates store operated Ca entry through interactions with STIM1. PLoS ONE 5, e12305 (2010).","journal-title":"PLoS ONE"},{"key":"BFnrneph201539_CR21","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1172\/JCI21753","volume":"114","author":"V Chauvet","year":"2004","unstructured":"Chauvet, V. et al. Mechanical stimuli induce cleavage and nuclear translocation of the polycystin-1 C terminus. J. Clin. Invest. 114, 1433\u20131443 (2004).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201539_CR22","doi-asserted-by":"publisher","first-page":"21011","DOI":"10.1074\/jbc.M109.017756","volume":"284","author":"CA Bertuccio","year":"2009","unstructured":"Bertuccio, C. A. et al. Polycystin-1 C-terminal cleavage is modulated by polycystin-2 expression. J. Biol. Chem. 284, 21011\u201321026 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201539_CR23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.devcel.2011.10.028","volume":"22","author":"D Merrick","year":"2012","unstructured":"Merrick, D. et al. The \u03b3-secretase cleavage product of polycystin-1 regulates TCF and CHOP-mediated transcriptional activation through a p300-dependent mechanism. Dev. Cell 22, 197\u2013210 (2012).","journal-title":"Dev. Cell"},{"key":"BFnrneph201539_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.devcel.2005.12.005","volume":"10","author":"SH Low","year":"2006","unstructured":"Low, S. H. et al. Polycystin-1, STAT6, and P100 function in a pathway that transduces ciliary mechanosensation and is activated in polycystic kidney disease. Dev. Cell 10, 57\u201369 (2006).","journal-title":"Dev. Cell"},{"key":"BFnrneph201539_CR25","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1046\/j.1523-1755.2001.060002484.x","volume":"60","author":"M Sutters","year":"2001","unstructured":"Sutters, M. et al. Polycystin-1 transforms the cAMP growth-responsive phenotype of M-1 cells. Kidney Int. 60, 484\u2013494 (2001).","journal-title":"Kidney Int."},{"key":"BFnrneph201539_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1152\/physiolgenomics.00092.2001","volume":"8","author":"DH Vandorpe","year":"2002","unstructured":"Vandorpe, D. H. et al. Cation channel regulation by COOH-terminal cytoplasmic tail of polycystin-1: mutational and functional analysis. Physiol. Genomics 8, 87\u201398 (2002).","journal-title":"Physiol. Genomics"},{"key":"BFnrneph201539_CR27","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0006-291X(02)03011-5","volume":"301","author":"G Aguiari","year":"2003","unstructured":"Aguiari, G. et al. Expression of polycystin-1 C-terminal fragment enhances the ATP-induced Ca2+ release in human kidney cells. Biochem. Biophys. Res. Commun. 301, 657\u2013664 (2003).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrneph201539_CR28","doi-asserted-by":"publisher","first-page":"F1168","DOI":"10.1152\/ajprenal.00171.2003","volume":"285","author":"SS Wildman","year":"2003","unstructured":"Wildman, S. S. et al. The isolated polycystin-1 cytoplasmic COOH terminus prolongs ATP-stimulated Cl\u2212 conductance through increased Ca2+ entry. Am. J. Physiol. Renal Physiol. 285, F1168\u2013F1178 (2003).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph201539_CR29","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1042\/CS20020239","volume":"104","author":"KM Hooper","year":"2003","unstructured":"Hooper, K. M., Unwin, R. J. & Sutters, M. The isolated C-terminus of polycystin-1 promotes increased ATP-stimulated chloride secretion in a collecting duct cell line. Clin. Sci. (Lond.) 104, 217\u2013221 (2003).","journal-title":"Clin. Sci. (Lond.)"},{"key":"BFnrneph201539_CR30","doi-asserted-by":"publisher","first-page":"55455","DOI":"10.1074\/jbc.M402905200","volume":"279","author":"S Puri","year":"2004","unstructured":"Puri, S. et al. Polycystin-1 activates the calcineurin\/NFAT (nuclear factor of activated T-cells) signaling pathway. J. Biol. Chem. 279, 55455\u201355464 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201539_CR31","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.yexcr.2004.10.023","volume":"304","author":"E Manzati","year":"2005","unstructured":"Manzati, E. et al. The cytoplasmic C-terminus of polycystin-1 increases cell proliferation in kidney epithelial cells through serum-activated and Ca2+-dependent pathway(s). Exp. Cell Res. 304, 391\u2013406 (2005).","journal-title":"Exp. Cell Res."},{"key":"BFnrneph201539_CR32","doi-asserted-by":"publisher","first-page":"F930","DOI":"10.1152\/ajprenal.00285.2006","volume":"292","author":"C Xu","year":"2007","unstructured":"Xu, C. et al. Human ADPKD primary cyst epithelial cells with a novel, single codon deletion in the PKD1 gene exhibit defective ciliary polycystin localization and loss of flow-induced Ca2+ signaling. Am. J. Physiol. Renal Physiol. 292, F930\u2013F945 (2007).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph201539_CR33","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1073\/pnas.98.3.1182","volume":"98","author":"S Gonz\u00e1lez-Perrett","year":"2001","unstructured":"Gonz\u00e1lez-Perrett, S. et al. Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channel. Proc. Natl Acad. Sci. USA 98, 1182\u20131187 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201539_CR34","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1006\/bbrc.2001.4554","volume":"282","author":"PM Vassilev","year":"2001","unstructured":"Vassilev, P. M. et al. Polycystin-2 is a novel cation channel implicated in defective intracellular Ca2+ homeostasis in polycystic kidney disease. Biochem. Biophys. Res. Commun. 282, 341\u2013350 (2001).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrneph201539_CR35","doi-asserted-by":"publisher","first-page":"11558","DOI":"10.1073\/pnas.0903684106","volume":"106","author":"Y Yu","year":"2009","unstructured":"Yu, Y. et al. Structural and molecular basis of the assembly of the TRPP2\/PKD1 complex. Proc. Natl Acad. Sci. USA 106, 11558\u201311563 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201539_CR36","doi-asserted-by":"publisher","first-page":"18994","DOI":"10.1074\/jbc.M110.192286","volume":"286","author":"S Feng","year":"2011","unstructured":"Feng, S., Rodat-Despoix, L., Delmas, P. & Ong, A. C. A single amino acid residue constitutes the third dimerization domain essential for the assembly and function of the tetrameric polycystin-2 (TRPP2) channel. J. Biol. Chem. 286, 18994\u201319000 (2011).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201539_CR37","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1038\/35050128","volume":"408","author":"K Hanaoka","year":"2000","unstructured":"Hanaoka, K. et al. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents. Nature 408, 990\u2013994 (2000).","journal-title":"Nature"},{"key":"BFnrneph201539_CR38","doi-asserted-by":"publisher","first-page":"5482","DOI":"10.1038\/ncomms6482","volume":"5","author":"H Kim","year":"2014","unstructured":"Kim, H. et al. Ciliary membrane proteins traffic through the Golgi via a Rabep1\/GGA1\/Arl3-dependent mechanism. Nat. Commun. 5, 5482 (2014).","journal-title":"Nat. Commun."},{"key":"BFnrneph201539_CR39","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1172\/JCI76972","volume":"125","author":"VG Gainullin","year":"2015","unstructured":"Gainullin, V. G., Hopp, K., Ward, C. J., Hommerding, C. J. & Harris, P.C. Polycystin-1 maturation requires polycystin-2 in a dose-dependent manner. J. Clin. Invest. 125, 607\u2013620 (2015).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201539_CR40","doi-asserted-by":"publisher","first-page":"36431","DOI":"10.1074\/jbc.M109.068916","volume":"284","author":"Y Li","year":"2009","unstructured":"Li, Y. et al. Polycystin-1 interacts with inositol 1,4,5-trisphosphate receptor to modulate intracellular Ca2+ signaling with implications for polycystic kidney disease. J. Biol. Chem. 284, 36431\u201336441 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201539_CR41","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1159\/000330080","volume":"27","author":"NG Santoso","year":"2011","unstructured":"Santoso, N. G., Cebotaru, L. & Guggino, W. B. Polycystin-1, 2, and STIM1 interact with IP3R. to modulate ER Ca2+ release through the PI3K\/Akt pathway. Cell Physiol. Biochem. 27, 715\u2013726 (2011).","journal-title":"Cell Physiol. Biochem."},{"key":"BFnrneph201539_CR42","doi-asserted-by":"publisher","first-page":"6454","DOI":"10.1073\/pnas.0610324104","volume":"104","author":"GI Anyatonwu","year":"2007","unstructured":"Anyatonwu, G. I., Estrada, M., Tian, X., Somlo, S. & Ehrlich, B. E. Regulation of ryanodine receptor-dependent calcium signaling by polycystin-2. Proc. Natl Acad. Sci. USA 104, 6454\u20136459 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201539_CR43","doi-asserted-by":"publisher","first-page":"3934","DOI":"10.1073\/pnas.96.7.3934","volume":"96","author":"L Tsiokas","year":"1999","unstructured":"Tsiokas, L. et al. Specific association of the gene product of PKD2 with the TRPC1 channel. Proc. Natl Acad. Sci. USA 96, 3934\u20133939 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201539_CR44","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/embor.2008.29","volume":"9","author":"CX Bai","year":"2008","unstructured":"Bai, C. X. et al. Formation of a new receptor-operated channel by heteromeric assembly of TRPP2 and TRPC1 subunits. EMBO Rep. 9, 472\u2013479 (2008).","journal-title":"EMBO Rep."},{"key":"BFnrneph201539_CR45","doi-asserted-by":"publisher","first-page":"F909","DOI":"10.1152\/ajprenal.00606.2007","volume":"294","author":"J Du","year":"2008","unstructured":"Du, J., Ding, M., Sours-Brothers, S., Graham, S. & Ma, R. Mediation of angiotensin II-induced Ca2+ signaling by polycystin 2 in glomerular mesangial cells. Am. J. Physiol. Renal Physiol. 294, F909\u2013F918 (2008).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph201539_CR46","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1083\/jcb.200805124","volume":"182","author":"M K\u00f6ttgen","year":"2008","unstructured":"K\u00f6ttgen, M. et al. TRPP2 and TRPV4 form a polymodal sensory channel complex. J. Cell Biol. 182, 437\u2013447 (2008).","journal-title":"J. Cell Biol."},{"key":"BFnrneph201539_CR47","doi-asserted-by":"publisher","first-page":"34400","DOI":"10.1074\/jbc.M109.015149","volume":"284","author":"K Miyagi","year":"2009","unstructured":"Miyagi, K. et al. A pathogenic C terminus-truncated polycystin-2 mutant enhances receptor-activated Ca2+ entry via association with TRPC3 and TRPC7. J. Biol. Chem. 284, 34400\u201334412 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201539_CR48","first-page":"386","volume":"401","author":"MM Barr","year":"1999","unstructured":"Barr, M. M. & Sternberg, P. W. A polycystic kidney-disease gene homologue required for male mating behaviour in C. elegans. Nature 401, 386\u2013389 (1999).","journal-title":"Nature"},{"key":"BFnrneph201539_CR49","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1242\/dev.128.9.1493","volume":"128","author":"CJ Haycraft","year":"2001","unstructured":"Haycraft, C. J., Swoboda, P., Taulman, P. D., Thomas, J. H. & Yoder, B. K. The C. elegans homolog of the murine cystic kidney disease gene Tg737 functions in a ciliogenic pathway and is disrupted in osm-5 mutant worms. Development 128, 1493\u20131505 (2001).","journal-title":"Development"},{"key":"BFnrneph201539_CR50","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00232-001-0075-4","volume":"184","author":"HA Praetorius","year":"2001","unstructured":"Praetorius, H. A. & Spring, K. R. Bending the MDCK cell primary cilium increases intracellular calcium. J. Membr. Biol. 184, 71\u201379 (2001).","journal-title":"J. Membr. Biol."},{"key":"BFnrneph201539_CR51","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/ng1076","volume":"33","author":"SM Nauli","year":"2003","unstructured":"Nauli, S. M. et al. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat. Genet. 33, 129\u2013137 (2003).","journal-title":"Nat. Genet."},{"key":"BFnrneph201539_CR52","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nature12833","volume":"504","author":"M Delling","year":"2013","unstructured":"Delling, M., DeCaen, P. G., Doerner, J. F., Febvay, S. & Clapham, D. E. Primary cilia are specialized calcium signalling organelles. Nature 504, 311\u2013314 (2013).","journal-title":"Nature"},{"key":"BFnrneph201539_CR53","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1007\/s00018-013-1483-1","volume":"71","author":"X Jin","year":"2014","unstructured":"Jin, X. et al. Cilioplasm is a cellular compartment for calcium signaling in response to mechanical and chemical stimuli. Cell. Mol. Life Sci. 71, 2165\u20132178 (2014).","journal-title":"Cell. Mol. Life Sci."},{"key":"BFnrneph201539_CR54","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1146\/annurev-physiol-021909-135825","volume":"72","author":"HA Praetorius","year":"2010","unstructured":"Praetorius, H. A. & Leipziger, J. Intrarenal purinergic signaling in the control of renal tubular transport. Annu. Rev. Physiol. 72, 377\u2013393 (2010).","journal-title":"Annu. Rev. Physiol."},{"key":"BFnrneph201539_CR55","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1748-1716.2009.02002.x","volume":"197","author":"HA Praetorius","year":"2009","unstructured":"Praetorius, H. A. & Leipziger, J. Released nucleotides amplify the cilium-dependent, flow-induced [Ca2+]i response in MDCK cells. Acta Physiol. (Oxf.) 197, 241\u2013251 (2009).","journal-title":"Acta Physiol. (Oxf.)"},{"key":"BFnrneph201539_CR56","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcdb.2012.10.003","volume":"24","author":"HA Praetorius","year":"2013","unstructured":"Praetorius, H. A. & Leipziger, J. Primary cilium-dependent sensing of urinary flow and paracrine purinergic signaling. Semin. Cell Dev. Biol. 24, 3\u201310 (2013).","journal-title":"Semin. Cell Dev. Biol."},{"key":"BFnrneph201539_CR57","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.ceca.2013.02.002","volume":"53","author":"L Rodat-Despoix","year":"2013","unstructured":"Rodat-Despoix, L., Hao, J., Dandonneau, M. & Delmas, P. Shear stress-induced Ca2+ mobilization in MDCK cells is ATP dependent, no matter the primary cilium. Cell Calcium 53, 327\u2013337 (2013).","journal-title":"Cell Calcium"},{"key":"BFnrneph201539_CR58","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/ncb754","volume":"4","author":"P Koulen","year":"2002","unstructured":"Koulen, P. et al. Polycystin-2 is an intracellular calcium release channel. Nat. Cell Biol. 4, 191\u2013197 (2002).","journal-title":"Nat. Cell Biol."},{"key":"BFnrneph201539_CR59","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1093\/hmg\/ddg190","volume":"12","author":"Q Qian","year":"2003","unstructured":"Qian, Q. et al. Pkd2 haploinsufficiency alters intracellular calcium regulation in vascular smooth muscle cells. Hum. Mol. Genet. 12, 1875\u20131880 (2003).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph201539_CR60","doi-asserted-by":"publisher","first-page":"19987","DOI":"10.1074\/jbc.M312031200","volume":"279","author":"Y Cai","year":"2004","unstructured":"Cai, Y. et al. Calcium dependence of polycystin-2 channel activity is modulated by phosphorylation at Ser812. J. Biol. Chem. 279, 19987\u201319995 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201539_CR61","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1096\/fj.03-0687fje","volume":"18","author":"G Aguiari","year":"2004","unstructured":"Aguiari, G. et al. Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells. FASEB J. 18, 884\u2013886 (2004).","journal-title":"FASEB J."},{"key":"BFnrneph201539_CR62","doi-asserted-by":"publisher","first-page":"14225","DOI":"10.1074\/jbc.M312223200","volume":"279","author":"Z Gao","year":"2004","unstructured":"Gao, Z., Joseph, E., Ruden, D. M. & Lu, X. Drosophila Pkd2 is haploid-insufficient for mediating optimal smooth muscle contractility. J. Biol. Chem. 279, 14225\u201314231 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201539_CR63","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.ceca.2005.03.003","volume":"37","author":"P Koulen","year":"2005","unstructured":"Koulen, P. et al. Polycystin-2 accelerates Ca2+ release from intracellular stores in Caenorhabditis elegans. Cell Calcium 37, 593\u2013601 (2005).","journal-title":"Cell Calcium"},{"key":"BFnrneph201539_CR64","doi-asserted-by":"publisher","first-page":"41298","DOI":"10.1074\/jbc.M510082200","volume":"280","author":"Y Li","year":"2005","unstructured":"Li, Y., Wright, J. M., Qian, F., Germino, G. G. & Guggino, W. B. Polycystin 2 interacts with type I inositol 1, 4, 5-trisphosphate receptor to modulate intracellular Ca2+ signaling. J. Biol. Chem. 280, 41298\u201341306 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201539_CR65","doi-asserted-by":"publisher","first-page":"15920","DOI":"10.1073\/pnas.0805062105","volume":"105","author":"L Geng","year":"2008","unstructured":"Geng, L. et al. Syntaxin 5 regulates the endoplasmic reticulum channel-release properties of polycystin-2. Proc. Natl Acad. Sci. USA 105, 15920\u201315925 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201539_CR66","doi-asserted-by":"publisher","first-page":"F1279","DOI":"10.1152\/ajprenal.00348.2007","volume":"294","author":"KH Weber","year":"2008","unstructured":"Weber, K. H. et al. Heterologous expression of polycystin-1 inhibits endoplasmic reticulum calcium leak in stably transfected MDCK cells. Am. J. Physiol. Renal Physiol. 294, F1279\u2013F1286 (2008).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph201539_CR67","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/emboj.2008.307","volume":"28","author":"T Wegierski","year":"2009","unstructured":"Wegierski, T. et al. TRPP2 channels regulate apoptosis through the Ca2+ concentration in the endoplasmic reticulum. EMBO J. 28, 490\u2013499 (2009).","journal-title":"EMBO J."},{"key":"BFnrneph201539_CR68","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ceca.2012.03.002","volume":"51","author":"D Mekahli","year":"2012","unstructured":"Mekahli, D. et al. Polycystin-1 and polycystin-2 are both required to amplify inositol-trisphosphate-induced Ca2+ release. Cell Calcium 51, 452\u2013458 (2012).","journal-title":"Cell Calcium"},{"key":"BFnrneph201539_CR69","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.yjmcc.2013.01.015","volume":"58","author":"J Paavola","year":"2013","unstructured":"Paavola, J. et al. Polycystin-2 mutations lead to impaired calcium cycling in the heart and predispose to dilated cardiomyopathy. J. Mol. Cellular Cardiol. 58, 199\u2013208 (2013).","journal-title":"J. Mol. Cellular Cardiol."},{"key":"BFnrneph201539_CR70","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1093\/hmg\/ddt031","volume":"22","author":"AJ Streets","year":"2013","unstructured":"Streets, A. J., Wessely, O., Peters, D. J. & Ong, A. C. Hyperphosphorylation of polycystin-2 at a critical residue in disease reveals an essential role for polycystin-1-regulated dephosphorylation. Hum. Mol. Genet. 22, 1924\u20131939 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph201539_CR71","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1083\/jcb.201012061","volume":"193","author":"OV Plotnikova","year":"2011","unstructured":"Plotnikova, O. V., Pugacheva, E. N. & Golemis, E. A. Aurora A kinase activity influences calcium signaling in kidney cells. J. Cell Biol. 193, 1021\u20131032 (2011).","journal-title":"J. Cell Biol."},{"key":"BFnrneph201539_CR72","doi-asserted-by":"publisher","first-page":"F521","DOI":"10.1152\/ajprenal.00355.2004","volume":"289","author":"K Hooper","year":"2005","unstructured":"Hooper, K. et al. Expression of polycystin-1 enhances endoplasmic reticulum calcium uptake and decreases capacitative calcium entry in ATP-stimulated MDCK cells. Am. J. Physiol. Renal Physiol. 289, F521\u2013F530 (2005).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph201539_CR73","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s00424-008-0561-y","volume":"457","author":"N Morel","year":"2009","unstructured":"Morel, N. et al. PKD1 haploinsufficiency is associated with altered vascular reactivity and abnormal calcium signaling in the mouse aorta. Pflugers Arch. 457, 845\u2013856 (2009).","journal-title":"Pflugers Arch."},{"key":"BFnrneph201539_CR74","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/ndt\/gfl150","volume":"21","author":"MY Chang","year":"2006","unstructured":"Chang, M. Y. et al. Haploinsufficiency of Pkd2 is associated with increased tubular cell proliferation and interstitial fibrosis in two murine Pkd2 models. Nephrol. Dial. Transplant. 21, 2078\u20132084 (2006).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201539_CR75","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/sj.ki.5002229","volume":"72","author":"E Parker","year":"2007","unstructured":"Parker, E. et al. Hyperproliferation of PKD1 cystic cells is induced by insulin-like growth factor-1 activation of the Ras\/Raf signalling system. Kidney Int. 72, 157\u2013165 (2007).","journal-title":"Kidney Int."},{"key":"BFnrneph201539_CR76","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1681\/ASN.2006010052","volume":"18","author":"AK Ahrabi","year":"2007","unstructured":"Ahrabi, A. K. et al. PKD1 haploinsufficiency causes a syndrome of inappropriate antidiuresis in mice. J. Am. Soc. Nephrol. 18, 1740\u20131753 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201539_CR77","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1681\/ASN.2005080830","volume":"17","author":"SM Nauli","year":"2006","unstructured":"Nauli, S. M. et al. Loss of polycystin-1 in human cyst-lining epithelia leads to ciliary dysfunction. J. Am. Soc. Nephrol. 17, 1015\u20131025 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201539_CR78","doi-asserted-by":"publisher","first-page":"14283","DOI":"10.1073\/pnas.1412323111","volume":"111","author":"IY Kuo","year":"2014","unstructured":"Kuo, I. Y. et al. Cyst formation following disruption of intracellular calcium signaling. Proc. Natl Acad. Sci. USA 111, 14283\u201314288 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201539_CR79","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/hep.24723","volume":"55","author":"C Spirli","year":"2012","unstructured":"Spirli, C. et al. Altered store operated calcium entry increases cyclic 3\u2032, 5\u2032-adenosine monophosphate production and extracellular signal-regulated kinases 1 and 2 phosphorylation in polycystin-2-defective cholangiocytes. Hepatology 55, 856\u2013868 (2012).","journal-title":"Hepatology"},{"key":"BFnrneph201539_CR80","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1093\/hmg\/ddh336","volume":"13","author":"IS Lantinga-van Leeuwen","year":"2004","unstructured":"Lantinga-van Leeuwen, I. S. et al. Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease. Hum. Mol. Genet. 13, 3069\u20133077 (2004).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph201539_CR81","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1093\/hmg\/9.18.2617","volume":"9","author":"L Pritchard","year":"2000","unstructured":"Pritchard, L. et al. A human PKD1 transgene generates functional polycystin-1 in mice and is associated with a cystic phenotype. Hum. Mol. Genet. 9, 2617\u20132627 (2000).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph201539_CR82","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1128\/MCB.26.4.1538-1548.2006","volume":"26","author":"C Thivierge","year":"2006","unstructured":"Thivierge, C. et al. Overexpression of PKD1 causes polycystic kidney disease. Mol. Cell Biol. 26, 1538\u20131548 (2006).","journal-title":"Mol. Cell Biol."},{"key":"BFnrneph201539_CR83","doi-asserted-by":"publisher","first-page":"7214","DOI":"10.1074\/jbc.M805890200","volume":"284","author":"EY Park","year":"2009","unstructured":"Park, E. Y. et al. Cyst formation in kidney via B-Raf signaling in the PKD2 transgenic mice. J. Biol. Chem. 284, 7214\u20137222 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201539_CR84","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S0272-6386(97)90496-0","volume":"30","author":"T Yamaguchi","year":"1997","unstructured":"Yamaguchi, T., Nagao, S., Kasahara, M., Takahashi, H. & Grantham, J. Renal accumulation and excretion of cyclic adenosine monophosphate in a murine model of slowly progressive polycystic kidney disease. Am. J. Kidney Dis. 30, 703\u2013709 (1997).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201539_CR85","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/nm935","volume":"9","author":"VH Gattone 2nd","year":"2003","unstructured":"Gattone, V. H. 2nd, Wang, X., Harris, P. C. & Torres, V. E. Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nat. Med. 9, 1323\u20131326 (2003).","journal-title":"Nat. Med."},{"key":"BFnrneph201539_CR86","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/ki.2008.111","volume":"73","author":"PG Starremans","year":"2008","unstructured":"Starremans, P. G. et al. A mouse model for polycystic kidney disease through a somatic in-frame deletion in the 5\u2032 end of Pkd1. Kidney Int. 73, 1394\u20131405 (2008).","journal-title":"Kidney Int."},{"key":"BFnrneph201539_CR87","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1681\/ASN.2006020136","volume":"17","author":"LA Smith","year":"2006","unstructured":"Smith, L. A. et al. Development of polycystic kidney disease in juvenile cystic kidney mice: insights into pathogenesis, ciliary abnormalities, and common features with human disease. J. Am. Soc. Nephrol. 17, 2821\u20132831 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201539_CR88","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1053\/j.gastro.2006.12.039","volume":"132","author":"TV Masyuk","year":"2007","unstructured":"Masyuk, T. V., Masyuk, A. I., Torres, V. E., Harris, P. C. & Larusso, N. F. Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3\u2032, 5\u2032-cyclic monophosphate. Gastroenterology 132, 1104\u20131116 (2007).","journal-title":"Gastroenterology"},{"key":"BFnrneph201539_CR89","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1161\/01.RES.0000163278.68142.8a","volume":"96","author":"SN Kip","year":"2005","unstructured":"Kip, S. N. et al. [Ca2+]i reduction increases cellular proliferation and apoptosis in vascular smooth muscle cells: relevance to the ADPKD phenotype. Circ. Res. 96, 873\u2013880 (2005).","journal-title":"Circ. Res."},{"key":"BFnrneph201539_CR90","doi-asserted-by":"publisher","first-page":"C1409","DOI":"10.1152\/ajpcell.00408.2006","volume":"292","author":"B Banizs","year":"2007","unstructured":"Banizs, B. et al. Altered pHi regulation and Na+\/HCO3\u2212 transporter activity in choroid plexus of cilia-defective Tg737orpk mutant mouse. Am. J. Physiol. Cell Physiol. 292, C1409\u2013C1416 (2007).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"BFnrneph201539_CR91","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/ki.2009.438","volume":"77","author":"X Wang","year":"2010","unstructured":"Wang, X., Ward, C. J., Harris, P. C. & Torres, V. E. Cyclic nucleotide signaling in polycystic kidney disease. Kidney Int. 77, 129\u2013140 (2010).","journal-title":"Kidney Int."},{"key":"BFnrneph201539_CR92","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1681\/ASN.2013010077","volume":"25","author":"S Rees","year":"2014","unstructured":"Rees, S. et al. Adenylyl cyclase 6 deficiency ameliorates polycystic kidney disease. J. Am. Soc. Nephrol. 25, 232\u2013237 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201539_CR93","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1681\/ASN.2013040421","volume":"25","author":"CR Sussman","year":"2014","unstructured":"Sussman, C. R. et al. Phosphodiesterase 1A modulates cystogenesis in zebrafish. J. Am. Soc. Nephrol. 25, 2222\u20132230 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201539_CR94","first-page":"F957","volume":"262","author":"M Yamaki","year":"1992","unstructured":"Yamaki, M., McIntyre, S., Rassier, M. E., Schwartz, J. H. & Dousa, T. P. Cyclic 3\u2032, 5\u2032-nucleotide diesterases in dynamics of cAMP and cGMP in rat collecting duct cells. Am. J. Physiol. 262, F957\u2013F964 (1992).","journal-title":"Am. J. Physiol."},{"key":"BFnrneph201539_CR95","first-page":"F956","volume":"249","author":"E Kusano","year":"1985","unstructured":"Kusano, E. et al. Effects of calcium on the vasopressin-sensitive cAMP metabolism in medullary tubules. Am. J. Physiol. 249, F956\u2013F966 (1985).","journal-title":"Am. J. Physiol."},{"key":"BFnrneph201539_CR96","doi-asserted-by":"publisher","first-page":"12331","DOI":"10.1074\/jbc.275.16.12331","volume":"275","author":"Y Kenan","year":"2000","unstructured":"Kenan, Y., Murata, T., Shakur, Y., Degerman, E. & Manganiello, V. C. Functions of the N-terminal region of cyclic nucleotide phosphodiesterase 3 (PDE 3) isoforms. J. Biol. Chem. 275, 12331\u201312338 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201539_CR97","doi-asserted-by":"publisher","first-page":"38749","DOI":"10.1074\/jbc.M001734200","volume":"275","author":"Y Shakur","year":"2000","unstructured":"Shakur, Y. et al. Membrane localization of cyclic nucleotide phosphodiesterase 3 (PDE3). Two N-terminal domains are required for the efficient targeting to, and association of, PDE3 with endoplasmic reticulum. J. Biol. Chem. 275, 38749\u201338761 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201539_CR98","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0022-2143(97)90121-9","volume":"130","author":"JJ Grantham","year":"1997","unstructured":"Grantham, J. J. Renal cell proliferation and the two faces of cyclic adenosine monophosphate. J. Lab. Clin. Med. 130, 459\u2013460 (1997).","journal-title":"J. Lab. Clin. Med."},{"key":"BFnrneph201539_CR99","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0022-2143(97)90125-6","volume":"130","author":"K Matousovic","year":"1997","unstructured":"Matousovic, K., Tsuboi, Y., Walker, H., Grande, J. P. & Dousa, T. P. Inhibitors of cyclic nucleotide phosphodiesterase isozymes block renal tubular cell proliferation induced by folic acid. J. Lab. Clin. Med. 130, 487\u2013495 (1997).","journal-title":"J. Lab. Clin. Med."},{"key":"BFnrneph201539_CR100","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1177\/153537020623100308","volume":"231","author":"J Cheng","year":"2006","unstructured":"Cheng, J. et al. Lixazinone stimulates mitogenesis of Madin\u2013Darby canine kidney cells. Exp. Biol. Med. (Maywood) 231, 288\u2013295 (2006).","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"BFnrneph201539_CR101","doi-asserted-by":"publisher","first-page":"C343","DOI":"10.1152\/ajpcell.00326.2013","volume":"306","author":"HR De Jonge","year":"2014","unstructured":"De Jonge, H. R. et al. cGMP inhibition of type 3 phosphodiesterase is the major mechanism by which C-type natriuretic peptide activates CFTR in the shark rectal gland. Am. J. Physiol. Cell Physiol. 306, C343\u2013C353 (2014).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"BFnrneph201539_CR102","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1091\/mbc.e09-08-0655","volume":"21","author":"H Penmatsa","year":"2010","unstructured":"Penmatsa, H. et al. Compartmentalized cyclic adenosine 3\u2032,5\u2032-monophosphate at the plasma membrane clusters PDE3A and cystic fibrosis transmembrane conductance regulator into microdomains. Mol. Biol.Cell 21, 1097\u20131110 (2010).","journal-title":"Mol. Biol.Cell"},{"key":"BFnrneph201539_CR103","doi-asserted-by":"publisher","first-page":"10679","DOI":"10.1073\/pnas.1016214108","volume":"108","author":"YH Choi","year":"2011","unstructured":"Choi, Y. H. et al. Polycystin-2 and phosphodiesterase 4C are components of a ciliary A-kinase anchoring protein complex that is disrupted in cystic kidney diseases. Proc. Natl Acad. Sci. USA 108, 10679\u201310684 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201539_CR104","doi-asserted-by":"publisher","first-page":"F1464","DOI":"10.1152\/ajprenal.90542.2008","volume":"296","author":"C Xu","year":"2009","unstructured":"Xu, C. et al. Attenuated, flow-induced ATP release contributes to absence of flow-sensitive, purinergic Cai2+ signaling in human ADPKD cyst epithelial cells. Am. J. Physiol. Renal Physiol. 296, F1464\u2013F1476 (2009).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph201539_CR105","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s11302-007-9072-0","volume":"4","author":"MB Hovater","year":"2008","unstructured":"Hovater, M. B. et al. Loss of apical monocilia on collecting duct principal cells impairs ATP secretion across the apical cell surface and ATP-dependent and flow-induced calcium signals. Purinergic Signal. 4, 155\u2013170 (2008).","journal-title":"Purinergic Signal."},{"key":"BFnrneph201539_CR106","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1161\/CIRCRESAHA.108.192765","volume":"104","author":"WA AbouAlaiwi","year":"2009","unstructured":"AbouAlaiwi, W. A. et al. Ciliary polycystin-2 is a mechanosensitive calcium channel involved in nitric oxide signaling cascades. Circ. Res. 104, 860\u2013869 (2009).","journal-title":"Circ. Res."},{"key":"BFnrneph201539_CR107","first-page":"629","volume":"53","author":"T Seeman","year":"2004","unstructured":"Seeman, T. et al. Renal concentrating capacity is linked to blood pressure in children with autosomal dominant polycystic kidney disease. Physiol. Res. 53, 629\u2013634 (2004).","journal-title":"Physiol. Res."},{"key":"BFnrneph201539_CR108","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.0954-6820.1986.tb03330.x","volume":"219","author":"H Danielsen","year":"1986","unstructured":"Danielsen, H. et al. Expansion of extracellular volume in early polycystic kidney disease. Acta Med. Scand. 219, 399\u2013405 (1986).","journal-title":"Acta Med. Scand."},{"key":"BFnrneph201539_CR109","first-page":"329","volume":"96","author":"A Michalski","year":"1996","unstructured":"Michalski, A. & Grzeszczak, W. The effect of hypervolemia on electrolyte level and level of volume regulating hormones in patients with autosomal dominant polycystic kidney disease. [Polish] Pol. Arch. Med. Wewn. 96, 329\u2013343 (1996).","journal-title":"Pol. Arch. Med. Wewn."},{"key":"BFnrneph201539_CR110","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.2215\/CJN.08690813","volume":"9","author":"D Zittema","year":"2014","unstructured":"Zittema, D. et al. Kidney function and plasma copeptin levels in healthy kidney donors and autosomal dominant polycystic kidney disease patients. Clin. J. Am. Soc. Nephrol. 9, 1553\u20131562 (2014).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201539_CR111","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1053\/j.ajkd.2012.08.038","volume":"61","author":"WE Boertien","year":"2013","unstructured":"Boertien, W. E. et al. Relationship of copeptin, a surrogate marker for arginine vasopressin, with change in total kidney volume and GFR decline in autosomal dominant polycystic kidney disease: results from the CRISP cohort. Am. J. Kidney Dis. 61, 420\u2013429 (2013).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201539_CR112","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2215\/CJN.04560510","volume":"6","author":"E Meijer","year":"2011","unstructured":"Meijer, E. et al. Copeptin, a surrogate marker of vasopressin, is associated with disease severity in autosomal dominant polycystic kidney disease. Clin. J. Am. Soc. Nephrol. 6, 361\u2013368 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201539_CR113","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.1093\/ndt\/gfs070","volume":"27","author":"WE Boertien","year":"2012","unstructured":"Boertien, W. E. et al. Copeptin, a surrogate marker for vasopressin, is associated with kidney function decline in subjects with autosomal dominant polycystic kidney disease. Nephrol. Dial. Transplant. 27, 4131\u20134137 (2012).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201539_CR114","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/ki.1989.38","volume":"35","author":"PA Gabow","year":"1989","unstructured":"Gabow, P. A. et al. The clinical utility of renal concentrating capacity in polycystic kidney disease. Kidney Int. 35, 675\u2013680 (1989).","journal-title":"Kidney Int."},{"key":"BFnrneph201539_CR115","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/(SICI)1520-6408(1999)24:3\/4<309::AID-DVG14>3.0.CO;2-5","volume":"24","author":"VH Gattone 2nd","year":"1999","unstructured":"Gattone, V. H. 2nd, Maser, R. L., Tian, C., Rosenberg, J. M. & Branden, M. G. Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease. Dev. Genet. 24, 309\u2013318 (1999).","journal-title":"Dev. Genet."},{"key":"BFnrneph201539_CR116","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nm1004","volume":"10","author":"VE Torres","year":"2004","unstructured":"Torres, V. E. et al. Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease. Nat. Med. 10, 363\u2013364 (2004).","journal-title":"Nat. Med."},{"key":"BFnrneph201539_CR117","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/ki.1988.2","volume":"33","author":"FA Carone","year":"1988","unstructured":"Carone, F. A., Ozono, S., Samma, S., Kanwar, Y. S. & Oyasu, R. Renal functional changes in experimental cystic disease are tubular in origin. Kidney Int. 33, 8\u201313 (1988).","journal-title":"Kidney Int."},{"key":"BFnrneph201539_CR118","first-page":"392","volume":"23","author":"M Safouh","year":"1970","unstructured":"Safouh, M., Crocker, J. F. & Vernier, R. L. Experimental cystic disease of the kidney. Sequential, functional, and morphologic studies. Lab. Invest. 23, 392\u2013400 (1970).","journal-title":"Lab. Invest."},{"key":"BFnrneph201539_CR119","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00467-010-1585-z","volume":"26","author":"MT Wolf","year":"2011","unstructured":"Wolf, M. T. & Hildebrandt, F. Nephronophthisis. Pediatr. Nephrol. 26, 181\u2013194 (2011).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph201539_CR120","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/ki.2010.538","volume":"79","author":"V Marion","year":"2011","unstructured":"Marion, V. et al. Bardet\u2013Biedl syndrome highlights the major role of the primary cilium in efficient water reabsorption. Kidney Int. 79, 1013\u20131025 (2011).","journal-title":"Kidney Int."},{"key":"BFnrneph201539_CR121","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000189556","volume":"75","author":"M Hayashi","year":"1997","unstructured":"Hayashi, M. et al. Expression and localization of the water channels in human autosomal dominant polycystic kidney disease. Nephron 75, 321\u2013326 (1997).","journal-title":"Nephron"},{"key":"BFnrneph201539_CR122","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1046\/j.1523-1755.1998.00990.x","volume":"54","author":"G Yasuda","year":"1998","unstructured":"Yasuda, G. & Jeffries, W. B. Regulation of cAMP production in initial and terminal inner medullary collecting ducts. Kidney Int. 54, 80\u201386 (1998).","journal-title":"Kidney Int."},{"key":"BFnrneph201539_CR123","first-page":"F261","volume":"308","author":"K Hopp","year":"2015","unstructured":"Hopp, K. et al. Effects of hydration in rats and mice with polycystic kidney disease. Am. J. Physiol. 308, F261\u2013F266 (2015).","journal-title":"Am. J. Physiol."},{"key":"BFnrneph201539_CR124","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1681\/ASN.2007060688","volume":"19","author":"X Wang","year":"2008","unstructured":"Wang, X., Wu, Y., Ward, C. J., Harris, P. C. & Torres, V. E. Vasopressin directly regulates cyst growth in polycystic kidney disease. J. Am. Soc. Nephrol. 19, 102\u2013108 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201539_CR125","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1681\/ASN.2004121090","volume":"16","author":"X Wang","year":"2005","unstructured":"Wang, X., Gattone, V. 2nd, Harris, P. C. & Torres, V. E. Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat. J. Am. Soc. Nephrol. 16, 846\u2013851 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201539_CR126","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1093\/ndt\/gfr069","volume":"26","author":"E Meijer","year":"2011","unstructured":"Meijer, E. et al. Therapeutic potential of vasopressin V2 receptor antagonist in a mouse model for autosomal dominant polycystic kidney disease: optimal timing and dosing of the drug. Nephrol. Dial. Transplant. 26, 2445\u20132453 (2011).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201539_CR127","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1681\/ASN.2013121312","volume":"26","author":"K Hopp","year":"2015","unstructured":"Hopp, K. et al. Tolvaptan plus pasireotide shows enhanced efficacy in a PKD1 model. J. Am. Soc. Nephrol. 26, 39\u201347 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201539_CR128","doi-asserted-by":"publisher","first-page":"F540","DOI":"10.1152\/ajprenal.00544.2009","volume":"300","author":"KP Yip","year":"2011","unstructured":"Yip, K. P. & Sham, J. S. Mechanisms of vasopressin-induced intracellular Ca2+ oscillations in rat inner medullary collecting duct. Am. J. Physiol. Renal Physiol. 300, F540\u2013F548 (2011).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph201539_CR129","doi-asserted-by":"publisher","first-page":"F341","DOI":"10.1152\/ajprenal.00190.2009","volume":"297","author":"E Odgaard","year":"2009","unstructured":"Odgaard, E., Praetorius, H. A. & Leipziger, J. AVP-stimulated nucleotide secretion in perfused mouse medullary thick ascending limb and cortical collecting duct. Am. J. Physiol. Renal Physiol. 297, F341\u2013F349 (2009).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph201539_CR130","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1096\/fj.07-8807com","volume":"21","author":"T Rieg","year":"2007","unstructured":"Rieg, T. et al. Mice lacking P2Y2 receptors have salt-resistant hypertension and facilitated renal Na+ and water reabsorption. FASEB J. 21, 3717\u20133726 (2007).","journal-title":"FASEB J."},{"key":"BFnrneph201539_CR131","doi-asserted-by":"publisher","first-page":"F863","DOI":"10.1152\/ajpcell.1995.269.4.C863","volume":"269","author":"BK Kishore","year":"1995","unstructured":"Kishore, B. K., Chou, C. L. & Knepper, M. A. Extracellular nucleotide receptor inhibits AVP-stimulated water permeability in inner medullary collecting duct. Am. J. Physiol. 269, F863\u2013F869 (1995).","journal-title":"Am. J. Physiol."},{"key":"BFnrneph201539_CR132","first-page":"F216","volume":"264","author":"I Teitelbaum","year":"1993","unstructured":"Teitelbaum, I. Protein kinase C inhibits arginine vasopressin-stimulated cAMP accumulation via a Gi-dependent mechanism. Am. J. Physiol. 264, F216\u2013F220 (1993).","journal-title":"Am. J. Physiol."},{"key":"BFnrneph201539_CR133","doi-asserted-by":"publisher","first-page":"F711","DOI":"10.1152\/ajprenal.00096.2003","volume":"285","author":"BD Welch","year":"2003","unstructured":"Welch, B. D., Carlson, N. G., Shi, H., Myatt, L. & Kishore, B. K. P2Y2 receptor-stimulated release of prostaglandin E2 by rat inner medullary collecting duct preparations. Am. J. Physiol. Renal Physiol. 285, F711\u2013F721 (2003).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph201539_CR134","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1681\/ASN.2012020217","volume":"24","author":"ET Olesen","year":"2013","unstructured":"Olesen, E. T. & Fenton, R. A. Is there a role for PGE2 in urinary concentration? J. Am. Soc. Nephrol. 24, 169\u2013178 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201539_CR135","doi-asserted-by":"publisher","first-page":"F1715","DOI":"10.1152\/ajprenal.90311.2008","volume":"295","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. et al. Potential role of purinergic signaling in urinary concentration in inner medulla: insights from P2Y2 receptor gene knockout mice. Am. J. Physiol. Renal Physiol. 295, F1715\u2013F1724 (2008).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph201539_CR136","doi-asserted-by":"publisher","first-page":"39397","DOI":"10.1074\/jbc.M207059200","volume":"277","author":"N DeSouza","year":"2002","unstructured":"DeSouza, N. et al. Protein kinase A and two phosphatases are components of the inositol 1,4,5-trisphosphate receptor macromolecular signaling complex. J. Biol. Chem. 277, 39397\u201339400 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201539_CR137","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.1113\/jphysiol.2008.152314","volume":"586","author":"LE Wagner 2nd","year":"2008","unstructured":"Wagner, L. E. 2nd, Joseph, S. K. & Yule, D. I. Regulation of single inositol 1,4,5-trisphosphate receptor channel activity by protein kinase A phosphorylation. J. Physiol. 586, 3577\u20133596 (2008).","journal-title":"J. Physiol."},{"key":"BFnrneph201539_CR138","doi-asserted-by":"publisher","first-page":"6381","DOI":"10.1113\/jphysiol.2012.237925","volume":"590","author":"DC Andersson","year":"2012","unstructured":"Andersson, D. C. et al. Stress-induced increase in skeletal muscle force requires protein kinase A phosphorylation of the ryanodine receptor. J. Physiol. 590, 6381\u20136387 (2012).","journal-title":"J. Physiol."},{"key":"BFnrneph201539_CR139","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0092-8674(00)80847-8","volume":"101","author":"SO Marx","year":"2000","unstructured":"Marx, S. O. et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101, 365\u2013376 (2000).","journal-title":"Cell"},{"key":"BFnrneph201539_CR140","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1146\/annurev-med-050913-022838","volume":"66","author":"VE Torres","year":"2015","unstructured":"Torres, V. E. Vasopressin receptor antagonists, heart failure, and polycystic kidney disease. Annu. Rev. Med. 66, 195\u2013210 (2015).","journal-title":"Annu. Rev. Med."},{"key":"BFnrneph201539_CR141","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1073\/pnas.0510113103","volume":"103","author":"XH Wehrens","year":"2006","unstructured":"Wehrens, X. H. et al. Ryanodine receptor\/calcium release channel PKA phosphorylation: a critical mediator of heart failure progression. Proc. Natl Acad. Sci. USA 103, 511\u2013518 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201539_CR142","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.bbrc.2009.09.071","volume":"390","author":"S Morimoto","year":"2009","unstructured":"Morimoto, S. et al. Protein kinase A-dependent phosphorylation of ryanodine receptors increases Ca2+ leak in mouse heart. Biochem. Biophys. Res. Commun. 390, 87\u201392 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrneph201539_CR143","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1172\/JCI62834","volume":"123","author":"AR Marks","year":"2013","unstructured":"Marks, A. R. Calcium cycling proteins and heart failure: mechanisms and therapeutics. J. Clin. Invest. 123, 46\u201352 (2013).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201539_CR144","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1681\/ASN.2013040398","volume":"25","author":"VE Torres","year":"2014","unstructured":"Torres, V. E. & Harris, P. C. Strategies targeting cAMP signaling in the treatment of polycystic kidney disease. J. Am. Soc. Nephrol. 25, 18\u201332 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201539_CR145","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1046\/j.1523-1755.2000.00991.x","volume":"57","author":"T Yamaguchi","year":"2000","unstructured":"Yamaguchi, T. et al. cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway. Kidney Int. 57, 1460\u20131471 (2000).","journal-title":"Kidney Int."},{"key":"BFnrneph201539_CR146","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1681\/ASN.V1171179","volume":"11","author":"K Hanaoka","year":"2000","unstructured":"Hanaoka, K. & Guggino, W. B. cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells. J. Am. Soc. Nephrol. 11, 1179\u20131187 (2000).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201539_CR147","doi-asserted-by":"publisher","first-page":"40419","DOI":"10.1074\/jbc.M405079200","volume":"279","author":"T Yamaguchi","year":"2004","unstructured":"Yamaguchi, T. et al. Calcium restriction allows cAMP activation of the B-Raf\/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype. J. Biol. Chem. 279, 40419\u201340430 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201539_CR148","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1681\/ASN.2005060645","volume":"17","author":"T Yamaguchi","year":"2006","unstructured":"Yamaguchi, T., Hempson, S. J., Reif, G. A., Hedge, A. M. & Wallace, D. P. Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells. J. Am. Soc. Nephrol. 17, 178\u2013187 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201539_CR149","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1242\/dev.066340","volume":"138","author":"SC Rothschild","year":"2011","unstructured":"Rothschild, S. C., Francescatto, L., Drummond, I. A. & Tombes, R. M. CaMK-II is a PKD2 target that promotes pronephric kidney development and stabilizes cilia. Development 138, 3387\u20133397 (2011).","journal-title":"Development"},{"key":"BFnrneph201539_CR150","first-page":"1591","volume":"466","author":"D Mekahli","year":"2014","unstructured":"Mekahli, D. et al. Polycystin-1 but not polycystin-2 deficiency causes upregulation of the mTOR pathway and can be synergistically targeted with rapamycin and metformin. Pflugers Arch. 466, 1591\u20131604 (2014).","journal-title":"Pflugers Arch."},{"key":"BFnrneph201539_CR151","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/j.bbadis.2014.06.001","volume":"1842","author":"X Jin","year":"2014","unstructured":"Jin, X. et al. L-type calcium channel modulates cystic kidney phenotype. Biochim. Biophys. Acta 1842, 1518\u20131526 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrneph201539_CR152","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/hep.22636","volume":"49","author":"JM Banales","year":"2009","unstructured":"Banales, J. M. et al. The cAMP effectors Epac and protein kinase A (PKA) are involved in the hepatic cystogenesis of an animal model of autosomal recessive polycystic kidney disease (ARPKD). Hepatology 49, 160\u2013174 (2009).","journal-title":"Hepatology"},{"key":"BFnrneph201539_CR153","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1093\/ndt\/gfn744","volume":"24","author":"DC Fischer","year":"2009","unstructured":"Fischer, D. C. et al. Activation of the AKT\/mTOR pathway in autosomal recessive polycystic kidney disease (ARPKD). Nephrol. Dial. Transplant. 24, 1819\u20131827 (2009).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201539_CR154","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1172\/JCI22850","volume":"115","author":"S Nishio","year":"2005","unstructured":"Nishio, S. et al. Pkd1 regulates immortalized proliferation of renal tubular epithelial cells through p53 induction and JNK activation. J. Clin. Invest. 115, 910\u2013918 (2005).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201539_CR155","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1440-1797.2007.00811.x","volume":"12","author":"PR Wahl","year":"2007","unstructured":"Wahl, P. R. et al. Mitotic activation of Akt signalling pathway in Han:SPRD rats with polycystic kidney disease. Nephrology (Carlton) 12, 357\u2013363 (2007).","journal-title":"Nephrology (Carlton)"},{"key":"BFnrneph201539_CR156","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/nm.2171","volume":"16","author":"TA Natoli","year":"2010","unstructured":"Natoli, T. A. et al. Inhibition of glucosylceramide accumulation results in effective blockade of polycystic kidney disease in mouse models. Nat. Med. 16, 788\u2013792 (2010).","journal-title":"Nat. Med."},{"key":"BFnrneph201539_CR157","doi-asserted-by":"publisher","first-page":"e87660","DOI":"10.1371\/journal.pone.0087660","volume":"9","author":"XS Ren","year":"2014","unstructured":"Ren, X. S. et al. Activation of the PI3K\/mTOR pathway is involved in cystic proliferation of cholangiocytes of the PCK rat. PloS ONE 9, e87660 (2014).","journal-title":"PloS ONE"},{"key":"BFnrneph201539_CR158","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1128\/MCB.01259-08","volume":"29","author":"G Distefano","year":"2009","unstructured":"Distefano, G. et al. Polycystin-1 regulates extracellular signal-regulated kinase-dependent phosphorylation of tuberin to control cell size through mTOR and its downstream effectors S6K and 4EBP1. Mol. Cell Biol. 29, 2359\u20132371 (2009).","journal-title":"Mol. Cell Biol."},{"key":"BFnrneph201539_CR159","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1002\/hep.23511","volume":"51","author":"C Spirli","year":"2010","unstructured":"Spirli, C. et al. Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice. Hepatology 51, 1778\u20131788 (2010).","journal-title":"Hepatology"},{"key":"BFnrneph201539_CR160","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.molmed.2011.06.003","volume":"17","author":"O Ibraghimov-Beskrovnaya","year":"2011","unstructured":"Ibraghimov-Beskrovnaya, O. & Natoli, T. A. mTOR signaling in polycystic kidney disease. Trends Mol. Med. 17, 625\u2013633 (2011).","journal-title":"Trends Mol. Med."},{"key":"BFnrneph201539_CR161","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/nm.3092","volume":"19","author":"I Rowe","year":"2013","unstructured":"Rowe, I. et al. Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy. Nat. Med. 19, 488\u2013493 (2013).","journal-title":"Nat. Med."},{"key":"BFnrneph201539_CR162","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.molcel.2010.06.022","volume":"39","author":"K Duvel","year":"2010","unstructured":"Duvel, K. et al. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol. Cell 39, 171\u2013183 (2010).","journal-title":"Mol. Cell"},{"key":"BFnrneph201539_CR163","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1158\/0008-5472.CAN-10-4158","volume":"71","author":"JL Yecies","year":"2011","unstructured":"Yecies, J. L. & Manning, B. D. Transcriptional control of cellular metabolism by mTOR signaling. Cancer Res. 71, 2815\u20132820 (2011).","journal-title":"Cancer Res."},{"key":"BFnrneph201539_CR164","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1073\/pnas.1011498108","volume":"108","author":"V Takiar","year":"2011","unstructured":"Takiar, V. et al. Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis. Proc. Natl Acad. Sci. USA 108, 2462\u20132467 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201539_CR165","doi-asserted-by":"publisher","first-page":"5972","DOI":"10.1038\/sj.onc.1204825","volume":"20","author":"S Saadi-Kheddouci","year":"2001","unstructured":"Saadi-Kheddouci, S. et al. Early development of polycystic kidney disease in transgenic mice expressing an activated mutant of the \u03b2-catenin gene. Oncogene 20, 5972\u20135981 (2001).","journal-title":"Oncogene"},{"key":"BFnrneph201539_CR166","doi-asserted-by":"publisher","first-page":"9356","DOI":"10.1128\/MCB.20.24.9356-9363.2000","volume":"20","author":"M Li","year":"2000","unstructured":"Li, M. et al. Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3\u03b2. Mol. Cell. Biol. 20, 9356\u20139363 (2000).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrneph201539_CR167","doi-asserted-by":"publisher","first-page":"9971","DOI":"10.1074\/jbc.M508778200","volume":"281","author":"S Taurin","year":"2006","unstructured":"Taurin, S., Sandbo, N., Qin, Y., Browning, D. & Dulin, N. O. Phosphorylation of \u03b2-catenin by cyclic AMP-dependent protein kinase. J. Biol. Chem. 281, 9971\u20139976 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201539_CR168","doi-asserted-by":"publisher","first-page":"3938","DOI":"10.1074\/jbc.M410697200","volume":"280","author":"CN Qian","year":"2005","unstructured":"Qian, C. N. et al. Cystic renal neoplasia following conditional inactivation of Apc in mouse renal tubular epithelium. J. Biol. Chem. 280, 3938\u20133945 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201539_CR169","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1681\/ASN.2011030277","volume":"23","author":"S Qin","year":"2012","unstructured":"Qin, S., Taglienti, M., Cai, L., Zhou, J. & Kreidberg, J. A. c-Met and NF-\u03baB-dependent overexpression of Wnt7a and -7b and Pax2 promotes cystogenesis in polycystic kidney disease. J. Am. Soc. Nephrol. 23, 1309\u20131318 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201539_CR170","doi-asserted-by":"publisher","first-page":"7985","DOI":"10.1073\/pnas.1103816108","volume":"108","author":"JJ Talbot","year":"2011","unstructured":"Talbot, J. J. et al. Polycystin-1 regulates STAT activity by a dual mechanism. Proc. Natl Acad. Sci. USA 108, 7985\u20137990 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201539_CR171","doi-asserted-by":"publisher","first-page":"F1193","DOI":"10.1152\/ajprenal.00419.2010","volume":"300","author":"WN Leonhard","year":"2011","unstructured":"Leonhard, W. N. et al. Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: in vivo evidence from a Pkd1-deletion model. Am. J. Physiol. Renal Physiol. 300, F1193\u2013F1202 (2011).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph201539_CR172","doi-asserted-by":"publisher","first-page":"4143","DOI":"10.1093\/hmg\/ddr338","volume":"20","author":"A Takakura","year":"2011","unstructured":"Takakura, A. et al. Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways. Hum. Mol. Genet. 20, 4143\u20134154 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph201539_CR173","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1093\/hmg\/ddl428","volume":"15","author":"C Stayner","year":"2006","unstructured":"Stayner, C. et al. Pax2 gene dosage influences cystogenesis in autosomal dominant polycystic kidney disease. Hum. Mol. Genet. 15, 3520\u20133528 (2006).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph201539_CR174","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1006\/dbio.2000.9618","volume":"219","author":"L Ostom","year":"2000","unstructured":"Ostom, L., Tang, M. J., Gruss, P. & Dressler, G. Reduced Pax2 gene dosage increases apoptosis and slows the progression of renal cystic disease. Dev. Biol. 219, 250\u2013258 (2000).","journal-title":"Dev. Biol."},{"key":"BFnrneph201539_CR175","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1152\/physrev.1998.78.4.1165","volume":"78","author":"LP Sullivan","year":"1998","unstructured":"Sullivan, L. P., Wallace, D. P. & Grantham, J. J. Epithelial transport in polycystic kidney disease. Physiol. Rev. 78, 1165\u20131191 (1998).","journal-title":"Physiol. Rev."},{"key":"BFnrneph201539_CR176","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1681\/ASN.V95903","volume":"9","author":"LP Sullivan","year":"1998","unstructured":"Sullivan, L. P., Wallace, D. P. & Grantham, J. J. Chloride and fluid secretion in polycystic kidney disease. J. Am. Soc. Nephrol 9, 903\u2013916 (1998).","journal-title":"J. Am. Soc. Nephrol"},{"key":"BFnrneph201539_CR177","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00109-010-0715-1","volume":"89","author":"B Buchholz","year":"2011","unstructured":"Buchholz, B., Teschemacher, B., Schley, G., Schillers, H. & Eckardt, K. U. Formation of cysts by principal-like MDCK cells depends on the synergy of cAMP- and ATP-mediated fluid secretion. J. Mol. Med. 89, 251\u2013261 (2011).","journal-title":"J. Mol. Med."},{"key":"BFnrneph201539_CR178","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/ki.2013.418","volume":"85","author":"B Buchholz","year":"2014","unstructured":"Buchholz, B. et al. Anoctamin 1 induces calcium-activated chloride secretion and proliferation of renal cyst-forming epithelial cells. Kidney Int. 85, 1058\u20131067 (2014).","journal-title":"Kidney Int."},{"key":"BFnrneph201539_CR179","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.ceca.2014.02.006","volume":"55","author":"Y Jang","year":"2014","unstructured":"Jang, Y. & Oh, U. Anoctamin 1 in secretory epithelia. Cell Calcium 55, 355\u2013361 (2014).","journal-title":"Cell Calcium"},{"key":"BFnrneph201539_CR180","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1073\/pnas.0700499104","volume":"104","author":"SJ Leuenroth","year":"2007","unstructured":"Leuenroth, S. J. et al. Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease. Proc. Natl Acad. Sci. USA 104, 4389\u20134394 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201539_CR181","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1681\/ASN.2008030259","volume":"19","author":"SJ Leuenroth","year":"2008","unstructured":"Leuenroth, S. J., Bencivenga, N., Igarashi, P., Somlo, S. & Crews, C. M. Triptolide reduces cystogenesis in a model of ADPKD. J. Am. Soc. Nephrol. 19, 1659\u20131662 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201539_CR182","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/sj.ki.5002629","volume":"73","author":"S Nagao","year":"2008","unstructured":"Nagao, S. et al. Calcium channel inhibition accelerates polycystic kidney disease progression in the Cy\/+ rat. Kidney Int. 73, 269\u2013277 (2008).","journal-title":"Kidney Int."},{"key":"BFnrneph201539_CR183","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1681\/ASN.2008090927","volume":"20","author":"VH Gattone 2nd","year":"2009","unstructured":"Gattone, V. H. 2nd et al. Calcimimetic inhibits late-stage cyst growth in ADPKD. J. Am. Soc. Nephrol. 20, 1527\u20131532 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201539_CR184","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1093\/ndt\/gfn527","volume":"24","author":"X Wang","year":"2009","unstructured":"Wang, X., Harris, P. C., Somlo, S., Batlle, D. & Torres, V. E. Effect of calcium-sensing receptor activation in models of autosomal recessive or dominant polycystic kidney disease. Nephrol. Dial. Transplant. 24, 526\u2013534 (2009).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201539_CR185","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1093\/ndt\/gfp777","volume":"25","author":"SJ Leuenroth","year":"2010","unstructured":"Leuenroth, S. J., Bencivenga, N., Chahboune, H., Hyder, F. & Crews, C. M. Triptolide reduces cyst formation in a neonatal to adult transition Pkd1 model of ADPKD. Nephrol. Dial. Transplant. 25, 2187\u20132194 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201539_CR186","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1053\/j.gastro.2010.04.010","volume":"139","author":"SA Gradilone","year":"2010","unstructured":"Gradilone, S. A. et al. Activation of Trpv4 reduces the hyperproliferative phenotype of cystic cholangiocytes from an animal model of ARPKD. Gastroenterology 139, 304\u2013314.e2 (2010).","journal-title":"Gastroenterology"},{"key":"BFnrneph201539_CR187","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/ki.2011.139","volume":"80","author":"NX Chen","year":"2011","unstructured":"Chen, N. X. et al. Calcimimetics inhibit renal pathology in rodent nephronophthisis. Kidney Int. 80, 612\u2013619 (2011).","journal-title":"Kidney Int."},{"key":"BFnrneph201539_CR188","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1615\/JEnvironPatholToxicolOncol.v31.i3.90","volume":"31","author":"N Mahajan","year":"2012","unstructured":"Mahajan, N. et al. Calcium ameliorates renal cyst growth in metanephric organ culture: a morphological study. J. Environ. Pathol. Toxicol. Oncol. 31, 285\u2013293 (2012).","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"key":"BFnrneph201539_CR189","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1681\/ASN.2012050442","volume":"24","author":"O Zaica","year":"2013","unstructured":"Zaica, O. et al. TRPV4 dysfunction promotes renal cystogenesis in autosomal recessive polycystic kidney disease. J. Am. Soc. Nephrol. 24, 604\u2013616 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201539_CR190","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1681\/ASN.2009050501","volume":"20","author":"VE Torres","year":"2009","unstructured":"Torres, V. E. Type II calcimimetics and polycystic kidney disease: unanswered questions. J. Am. Soc. Nephrol. 20, 1421\u20131425 (2009).","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2015.39.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2015.39","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2015.39.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:46:58Z","timestamp":1684457218000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2015.39"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,14]]},"references-count":190,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["BFnrneph201539"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2015.39","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,14]]},"assertion":[{"value":"14 April 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"V.E.T. is principal investigator for several clinical trials of tolvaptan in ADPKD and has received research support from Otsuka Pharmaceutical. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}